Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 17;39(4):364-372.
doi: 10.1055/s-0042-1757314. eCollection 2022 Aug.

Anticoagulation and Antiplatelet Agents in Peripheral Arterial Interventions

Jordan Taylor  1 , Henry R Stiepel 3rd  1 , Nicole Keefe  1
Affiliations
Review

Anticoagulation and Antiplatelet Agents in Peripheral Arterial Interventions

Jordan Taylor et al. Semin Intervent Radiol. .

Abstract

Effective revascularization of peripheral artery disease relies on periprocedural pharmacological regulation of the clotting cascade. Patient-specific factors such as cardiovascular risk factors, contraindications, and individual psychosocial factors must be considered when initiating post revascularization management. Management with anticoagulant and antiplatelet agents is discussed to guide the interventionalist on which therapy may be appropriate for their patient. While exact treatment may be institution and provider dependent, the interventionist must be familiar with the available classes of medications and how they can be prescribed in the postprocedural setting to improve cardiovascular outcomes.

Keywords: anticoagulant; antiplatelet; dual-antiplatelet therapy; interventional radiology; peripheral artery disease.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

References

    1. Lopez A D, Murray C CJL. The global burden of disease, 1990-2020. Nat Med. 1998;4(11):1241–1243. - PubMed
    1. Guez D, Hansberry D R, Gonsalves C F. Recent trends in endovascular and surgical treatment of peripheral arterial disease in the Medicare population. AJR Am J Roentgenol. 2020;214(05):962–966. - PubMed
    1. Davidson J C, Rahim S, Hanks S E. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part I: Review of anticoagulation agents and clinical considerations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol. 2019;30(08):1155–1167. - PubMed
    1. Wiersema A M, Watts C, Durran A C. The use of heparin during endovascular peripheral arterial interventions: a synopsis. Scientifica (Cairo) 2016;2016:1.456298E6. - PMC - PubMed
    1. Paez Espinosa E V, Murad J P, Khasawneh F T. Aspirin: pharmacology and clinical applications. Thrombosis. 2012;2012:173124. - PMC - PubMed